1-5 of 5
eosinophilia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A novel activating JAK1 mutation in chronic eosinophilic leukemia

William Shomali, Alisa Damnernsawad, Talent Theparee, David Sampson, Quinlan Morrow, Fei Yang, Sebastian Fernandez-Pol, Richard Press, James Zehnder, Jeffrey W. Tyner, Jason Gotlib
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3581–3586.
https://doi.org/10.1182/bloodadvances.2021004237
Published: 2021
Includes: Supplemental data
Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Clinical Trials & Observations
Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1899–1902.
https://doi.org/10.1182/bloodadvances.2020003699
Published: 2021
Journal Articles

Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia

Clinical Trials & Observations
Monica Kasbekar, Valentina Nardi, Paola Dal Cin, Andrew M. Brunner, Meghan Burke, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, Julia Foster, Molly Macrae, Steven L. McAfee, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, Meghan Vartanian, Robb S. Friedman, Karim A. Benhadji, Gabriela S. Hobbs
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3136–3140.
https://doi.org/10.1182/bloodadvances.2020002308
Published: 2020
Journal Articles

A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia

Clinical Trials & Observations
Max Jan, Daniel E. Grinshpun, Julian A. Villalba, Paola Dal Cin, David B. Sykes, A. John Iafrate, Benjamin L. Ebert, Gabriela S. Hobbs, Valentina Nardi
Journal: Blood Advances
Blood Adv (2020) 4 (3): 445–448.
https://doi.org/10.1182/bloodadvances.2019001182
Published: 2020
Journal Articles

Treatment-free remission in FIP1L1-PDGFRA –positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation

Clinical Trials & Observations
Georgia Metzgeroth, Juliana Schwaab, Nicole Naumann, Mohamad Jawhar, Torsten Haferlach, Alice Fabarius, Andreas Hochhaus, Wolf-Karsten Hofmann, Nicholas C. P. Cross, Andreas Reiter
Journal: Blood Advances
Blood Adv (2020) 4 (3): 440–443.
https://doi.org/10.1182/bloodadvances.2019001111
Published: 2020